Previsioni di mercato dei kit per test rapidi per il Nord America fino al 2030 - Analisi regionale - per tipo (test rapido dell\'antigene, test rapido degli anticorpi e altri), prodotto (kit di test rapido da banco e kit di test rapido professionale), tecnologia (test a flusso laterale , fase solida, agglutinazione, test immunospot e basato su componenti cellulari), applicazione (test della glicemia, test delle malattie infettive, gravidanza e fertilità, test cardiometabolici e altri) e utente finale (ospedali e cliniche, assistenza domiciliare, centri diagnostici , e altri)
La crescente prevalenza di malattie genetiche e infettive alimenta il mercato dei kit per test rapidi in Nord America
Un rapporto del 2022 di MJH Life Sciences (USA ) stima che ogni anno nel mondo nascono 300.000 neonati affetti da anemia falciforme. Secondo il CDC, 1 afroamericano su 500 è affetto da anemia falciforme. L’ultimo World Malaria Report (WMR) 2022 dell’Organizzazione Mondiale della Sanità (OMS) afferma che quasi 247 milioni di nuovi casi di malaria sono stati segnalati nel mondo nel 2021, rispetto ai 245 milioni di casi registrati nel 2020. Secondo la stessa fonte , il numero di decessi causati dalla malaria è stato di 619.000 nel 2021.
Sickle SCAN è un test rapido per l\'identificazione dell\'anemia falciforme con elevata sensibilità e specificità. I test diagnostici rapidi (RDT) aiutano a diagnosticare la malaria rilevando la presenza di parassiti malarici nel sangue umano. Laddove l’accesso a servizi di microscopia di alta qualità è limitato, le tecniche di diagnosi radiologica vengono utilizzate come alternativa alla diagnosi clinica o basata sul microscopio. La pandemia COVID-19 ha avuto un impatto significativo sul mercato dei kit di test rapidi. Quasi tutti i test diagnostici hanno utilizzato la PCR in tempo reale per testare le persone che mostravano sintomi di infezione da SARS-CoV-2. I kit di test rapidi sono quasi onnipresenti, robusti e affidabili. Nella maggior parte dei laboratori di biologia molecolare vengono utilizzate tecniche di test rapidi che comportano l\'amplificazione di tratti specifici di DNA per la genotipizzazione, la clonazione e l\'analisi delle variazioni di singoli nucleotidi. Pertanto, la crescente incidenza di malattie genetiche e infettive spinge la crescita del mercato dei kit di test rapidi.
Panoramica del mercato dei kit per test rapidi in Nord America
La rapida adozione di strumenti di sintesi e modifica genetica come CRISPR e PCR nella ricerca e nelle terapie richiede test utili in termini di quantificazione rapida, alterazioni, e osservazione. Si prevede che gli Stati Uniti, alla ricerca di finanziamenti significativi da parte di organizzazioni pubbliche e private, investiranno in modo significativo in metodologie di ricerca avanzate e saranno in una posizione di leadership nel mercato dei kit di test rapidi. Si è verificato un rapido aumento nell’uso dei test a domicilio tra i periodi della pandemia in cui predominano SARS-CoV-2 Delta e Omicron. Secondo il CDC, nell’aprile 2023, negli Stati Uniti sono stati spediti più di 70 milioni di kit di test.
Entrate e previsioni del mercato dei kit per test rapidi in Nord America fino al 2030 (milioni di dollari)
Segmentazione del mercato dei kit per test rapidi in Nord America
Il mercato dei kit per test rapidi in Nord America è segmentato in base al tipo, al prodotto, alla tecnologia, all\'applicazione, all\'utente finale e al Paese. In base al tipo, il mercato dei kit per test rapidi in Nord America è segmentato in test rapidi dell’antigene, test rapidi degli anticorpi e altri. Il segmento dei test rapidi per l\'antigene ha detenuto la quota di mercato maggiore nel 2022.
In termini di prodotto, il mercato dei kit per test rapidi in Nord America è biforcato in kit per test rapidi da banco e kit per test rapidi professionali. Il segmento dei kit per test rapidi da banco ha detenuto una quota di mercato maggiore nel 2022.
In base alla tecnologia, il mercato dei kit per test rapidi in Nord America è segmentato in test a flusso laterale, fase solida, agglutinazione, test immunospot e test basato su componenti cellulari. Il segmento dei test a flusso laterale ha detenuto la quota di mercato maggiore nel 2022.
In base all\'applicazione, il mercato dei kit per test rapidi del Nord America è classificato in test della glicemia, test di malattie infettive, gravidanza e fertilità, test cardiometabolici e altri . Il segmento dei test della glicemia ha detenuto la quota di mercato maggiore nel 2022.
In termini di utente finale, il mercato dei kit per test rapidi del Nord America è segmentato in ospedali e cliniche, assistenza domiciliare, centri diagnostici e altri. Il segmento ospedali e cliniche ha detenuto la quota di mercato maggiore nel 2022.
In base al paese, il mercato dei kit per test rapidi in Nord America è segmentato negli Stati Uniti, Canada e Messico. Gli Stati Uniti hanno dominato la quota di mercato dei kit per test rapidi in Nord America nel 2022.
F. Hoffmann-La Roche Ltd, Becton Dickinson and Co, ARKRAY Inc, Fujirebio Europe NV, bioMerieux SA, Cepheid, Meril Life Sciences Pvt Ltd, QIAGEN NV, OraSure Technologies Inc, Guangzhou Wondfo Biotech Co Ltd, Denka Co Ltd, Abbott Laboratories, Trinity Biotech Plc, SD Biosensor Inc, Bio-Rad Laboratories Inc, Hologic Inc, DiaSorin SpA e Beckman Coulter Inc sono alcuni dei principali attori che operano nel mercato dei kit per test rapidi del Nord America.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Rapid Test Kits Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rising Prevalence of Genetic and Infectious Diseases
4.1.2 Strategic Initiatives by Manufacturers
4.2 Market Restraints
4.2.1 Uncertainties Related to Accuracy of Results
4.3 Market Opportunities
4.3.1 Increasing Preference for PCR Techniques
4.4 Future Trends
4.4.1 Innovations in Rapid Antigen Tests
4.5 Impact Analysis
5. Rapid Test Kits Market - North America Market Analysis
5.1 Overview
5.2 Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030
6. North America Rapid Test Kits Market Analysis - by Type
6.1 Overview
6.2 Rapid Antigen Testing
6.2.1 Overview
6.2.2 Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Rapid Antibody Testing
6.3.1 Overview
6.3.2 Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
7. North America Rapid Test Kits Market Analysis - by Product
7.1 Overview
7.2 Over-the-Counter Rapid Testing Kit
7.2.1 Overview
7.2.2 Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Professional Rapid Testing Kit
7.3.1 Overview
7.3.2 Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8. North America Rapid Test Kits Market Analysis - by Technology
8.1 Overview
8.2 Lateral Flow Assay
8.2.1 Overview
8.2.2 Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Solid Phase
8.3.1 Overview
8.3.2 Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Agglutination
8.4.1 Overview
8.4.2 Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Immunospot Assay
8.5.1 Overview
8.5.2 Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Cellular-Component Based
8.6.1 Overview
8.6.2 Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9. North America Rapid Test Kits Market Analysis - by Application
9.1 Overview
9.2 Blood Glucose Testing
9.2.1 Overview
9.2.2 Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Infectious Disease Testing
9.3.1 Overview
9.3.2 Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.3.3 Infectious Disease Testing: Rapid Test Kits Market, by Application - Revenue and Forecast to 2030 (US$ Million)
9.4 Cardiometabolic Testing
9.4.1 Overview
9.4.2 Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Pregnancy and Fertility
9.5.1 Overview
9.5.2 Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10. North America Rapid Test Kits Market Analysis - by End User
10.1 Overview
10.2 Hospital and Clinics
10.2.1 Overview
10.2.2 Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10.3 Diagnostic Centers
10.3.1 Overview
10.3.2 Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Home-Care
10.4.1 Overview
10.4.2 Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11. North America Rapid Test Kits Market - Country Analysis
11.1 North America: Rapid Test Kits Market
11.1.1 North America: Rapid Test Kits Market - Revenue and Forecast Analysis - by Country
11.1.1.1 United States
11.1.1.1.1 Overview
11.1.1.2 United States: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.2.1 United States: Rapid Test Kits Market Breakdown, by Type
11.1.1.2.2 United States: Rapid Test Kits Market Breakdown, by Product
11.1.1.2.3 United States: Rapid Test Kits Market Breakdown, by Technology
11.1.1.2.4 United States: Rapid Test Kits Market Breakdown, by Application
11.1.1.2.4.1 United States: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.2.5 United States: Rapid Test Kits Market Breakdown, by End User
11.1.1.3 Canada
11.1.1.3.1 Overview
11.1.1.4 Canada: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.4.1 Canada: Rapid Test Kits Market Breakdown, by Type
11.1.1.4.2 Canada: Rapid Test Kits Market Breakdown, by Product
11.1.1.4.3 Canada: Rapid Test Kits Market Breakdown, by Technology
11.1.1.4.4 Canada: Rapid Test Kits Market Breakdown, by Application
11.1.1.4.4.1 Canada: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.4.5 Canada: Rapid Test Kits Market Breakdown, by End User
11.1.1.5 Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.5.1 Overview
11.1.1.6 Mexico
11.1.1.6.1 Mexico: Rapid Test Kits Market Breakdown, by Type
11.1.1.6.2 Mexico: Rapid Test Kits Market Breakdown, by Product
11.1.1.6.3 Mexico: Rapid Test Kits Market Breakdown, by Technology
11.1.1.6.4 Mexico: Rapid Test Kits Market Breakdown, by Application
11.1.1.6.4.1 Mexico: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.6.5 Mexico: Rapid Test Kits Market Breakdown, by End User
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Rapid Test Kit Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 F. Hoffmann-La Roche Ltd
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Becton Dickinson and Co
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 ARKRAY Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Fujirebio Europe NV
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 bioMerieux SA
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Cepheid
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Meril Life Sciences Pvt Ltd
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 QIAGEN NV
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 OraSure Technologies Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Guangzhou Wondfo Biotech Co Ltd
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Denka Co Ltd
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Abbott Laboratories
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
13.13 Trinity Biotech Plc
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments
13.14 SD Biosensor Inc
13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Products and Services
13.14.4 Financial Overview
13.14.5 SWOT Analysis
13.14.6 Key Developments
13.15 Bio-Rad Laboratories Inc
13.15.1 Key Facts
13.15.2 Business Description
13.15.3 Products and Services
13.15.4 Financial Overview
13.15.5 SWOT Analysis
13.15.6 Key Developments
13.16 Hologic Inc
13.16.1 Key Facts
13.16.2 Business Description
13.16.3 Products and Services
13.16.4 Financial Overview
13.16.5 SWOT Analysis
13.16.6 Key Developments
13.17 DiaSorin SpA
13.17.1 Key Facts
13.17.2 Business Description
13.17.3 Products and Services
13.17.4 Financial Overview
13.17.5 SWOT Analysis
13.17.6 Key Developments
13.18 Beckman Coulter Inc
13.18.1 Key Facts
13.18.2 Business Description
13.18.3 Products and Services
13.18.4 Financial Overview
13.18.5 SWOT Analysis
13.18.6 Key Developments
14. Appendix
14.1 About The Insight Partners
List of Tables
Table 1. Rapid Test Kits Market Segmentation
Table 2. Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 4. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 5. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
Table 6. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 7. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
Table 8. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 9. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 10. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 11. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
Table 12. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 13. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
Table 14. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 15. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 16. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 17. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
Table 18. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 19. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
Table 20. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 21. Recent Inorganic Growth Strategies in the Rapid Test Kit Market
Table 22. Recent Organic Growth Strategies in the Rapid Test Kit Market
List of Figures
Figure 1. Rapid Test Kits Market Segmentation, By Country
Figure 2. Rapid Test Kits Market: Key Industry Dynamics
Figure 3. Rapid Test Kits Market: Impact Analysis of Drivers and Restraints
Figure 4. Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Rapid Test Kits Market Share (%) - by Type (2022 and 2030)
Figure 6. Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Rapid Test Kits Market Share (%) - by Product (2022 and 2030)
Figure 10. Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Rapid Test Kits Market Share (%) - by Technology (2022 and 2030)
Figure 13. Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Rapid Test Kits Market Share (%) - by Application (2022 and 2030)
Figure 19. Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Rapid Test Kits Market Share (%) - by End User (2022 and 2030)
Figure 25. Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. North America: Rapid Test Kits Market, by Key Country - Revenue (2022) (US$ Million)
Figure 30. North America: Rapid Test Kits Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 31. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
Figure 32. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
Figure 33. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
Figure 34. Growth Strategies in the Rapid Test Kit Market
1. F. Hoffmann-La Roche Ltd
2. Becton Dickinson and Co
3. ARKRAY Inc
4. Fujirebio Europe NV
5. bioMerieux SA
6. Cepheid
7. Meril Life Sciences Pvt Ltd
8. QIAGEN NV
9. OraSure Technologies Inc
10. Guangzhou Wondfo Biotech Co Ltd
11. Denka Co Ltd
12. Abbott Laboratories
13. Trinity Biotech Plc
14. SD Biosensor Inc
15. Bio-Rad Laboratories Inc
16. Hologic Inc
17. DiaSorin SpA
18. Beckman Coulter Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America rapid test kit market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America rapid test kit market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America rapid test kit market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.